A 63-year-old with type 2 diabetes and BMI 35 kg/m² has inadequate glycaemic control on metformin and SGLT2 inhibitor. Established CVD present. Next e...

Question

A 63-year-old with type 2 diabetes and BMI 35 kg/m² has inadequate glycaemic control on metformin and SGLT2 inhibitor. Established CVD present. Next escalation prioritising weight and CV benefit?

Accepted Answer

Add GLP-1 receptor agonist

Answer

Add sulfonylurea

Answer

Add DPP-4 inhibitor

Answer

Start basal insulin

Answer

Double metformin dose above max

ukmla MCQ (SBA): T2DM therapy optimisation

A 63-year-old with type 2 diabetes and BMI 35 kg/m² has inadequate glycaemic control on metformin and SGLT2 inhibitor. Established CVD present. Next escalation prioritising weight and CV benefit?